Skip to main content
Top
Published in: Translational Stroke Research 5/2015

01-10-2015 | Pilot Clinical Trials

The Women Independently Living Alone with a Medical Alert Device (WILMA) trial

Authors: Lewis B. Morgenstern, Eric E. Adelman, Rebecca Hughes, Jeffrey J. Wing, Lynda D. Lisabeth

Published in: Translational Stroke Research | Issue 5/2015

Login to get access

Abstract

Women are more likely to live alone compared with men, and therefore have more difficulty activating emergency medical systems for stroke. The goal of this study was to examine the benefit of wearing medical alert devices to activate emergency medical systems for elderly women living alone. This was a randomized, controlled pilot trial. Women over 60 with at least 1 stroke risk factor were recruited from Southeast Michigan. Subjects received either a medical alert device or control. The primary outcome was change in health-related quality of life (HRQOL) from baseline to 90 days of wearing the device or control. A planned sample size of 320 could not be reached, and the trial was stopped at 265 women randomized prior to data examination. On average, the treatment group was older, reported lower prevalence of high cholesterol, and was less likely to complete follow-up. There was a nonsignificant smaller loss of healthy days in the past month in the intervention group (0.46) compared with the control group (2.23) (p = 0.213). Similarly, the secondary outcomes of changes in anxiety, depression, and changes in perceived isolation did not differ by treatment and control groups. This study did not establish improvement in HRQOL among women who wore the device compared with those that did not, nor the feasibility of a trial to study the efficacy of medical alert devices in elderly women. Newer devices that use cellular technology may be more accepted than the landline-based system used in this study.
Literature
1.
go back to reference Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, et al. Global burden of diseases I, risk factors S, the GBDSEG. Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet. 2014;383:245–54.PubMedCentralCrossRefPubMed Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, et al. Global burden of diseases I, risk factors S, the GBDSEG. Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet. 2014;383:245–54.PubMedCentralCrossRefPubMed
3.
go back to reference Lisabeth LD, Reeves MJ, Baek J, Skolarus LE, Brown DL, et al. Factors influencing sex differences in poststroke functional outcome. Stroke. 2015;46:860–3.CrossRefPubMed Lisabeth LD, Reeves MJ, Baek J, Skolarus LE, Brown DL, et al. Factors influencing sex differences in poststroke functional outcome. Stroke. 2015;46:860–3.CrossRefPubMed
4.
go back to reference Wein TH, Staub L, Felberg R, Hickenbottom SL, Chan W, et al. Activation of emergency medical services for acute stroke in a nonurban population: the T.L.L. Temple foundation stroke project. Stroke. 2000;31:1925–28.CrossRefPubMed Wein TH, Staub L, Felberg R, Hickenbottom SL, Chan W, et al. Activation of emergency medical services for acute stroke in a nonurban population: the T.L.L. Temple foundation stroke project. Stroke. 2000;31:1925–28.CrossRefPubMed
5.
go back to reference Reeves MJ, Prager M, Fang J, Stamplecoski M, Kapral MK. Impact of living alone on the care and outcomes of patients with acute stroke. Stroke. 2014;45:3083–5.CrossRefPubMed Reeves MJ, Prager M, Fang J, Stamplecoski M, Kapral MK. Impact of living alone on the care and outcomes of patients with acute stroke. Stroke. 2014;45:3083–5.CrossRefPubMed
6.
go back to reference Heller DA, Gold CH, Ahern FM, Pringle KE, Brown TV, Glessner MR. Changes in elderly women’s health-related quality of life following discontinuation of hormone replacement therapy. BMC Womens Health. 2005;5:7.PubMedCentralCrossRefPubMed Heller DA, Gold CH, Ahern FM, Pringle KE, Brown TV, Glessner MR. Changes in elderly women’s health-related quality of life following discontinuation of hormone replacement therapy. BMC Womens Health. 2005;5:7.PubMedCentralCrossRefPubMed
7.
go back to reference Browall MM, Ahlberg KM, Persson LO, Karlsson PO, Danielson EB. The impact of age on health-related quality of life (hrqol) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy. Acta Oncol. 2008;47:207–15.CrossRefPubMed Browall MM, Ahlberg KM, Persson LO, Karlsson PO, Danielson EB. The impact of age on health-related quality of life (hrqol) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy. Acta Oncol. 2008;47:207–15.CrossRefPubMed
8.
go back to reference Cornwell EY, Waite LJ. Measuring social isolation among older adults using multiple indicators from the nshap study. J Gerontol B Psychol Sci Soc Sci. 2009;64 Suppl 1:i38–46.CrossRefPubMed Cornwell EY, Waite LJ. Measuring social isolation among older adults using multiple indicators from the nshap study. J Gerontol B Psychol Sci Soc Sci. 2009;64 Suppl 1:i38–46.CrossRefPubMed
9.
go back to reference Silver FL, Rubini F, Black D, Hodgson CS. Advertising strategies to increase public knowledge of the warning signs of stroke. Stroke. 2003;34:1965–8.CrossRefPubMed Silver FL, Rubini F, Black D, Hodgson CS. Advertising strategies to increase public knowledge of the warning signs of stroke. Stroke. 2003;34:1965–8.CrossRefPubMed
10.
11.
go back to reference Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB. Acute stroke symptoms: comparing women and men. Stroke. 2009;40:2031–36.CrossRefPubMed Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB. Acute stroke symptoms: comparing women and men. Stroke. 2009;40:2031–36.CrossRefPubMed
12.
go back to reference Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis: of cases, controls, and treatment-effect modification. Neurology. 2008;71:1080–3.CrossRefPubMed Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis: of cases, controls, and treatment-effect modification. Neurology. 2008;71:1080–3.CrossRefPubMed
13.
go back to reference Smith MA, Lisabeth LD, Bonikowski F, Morgenstern LB. The role of ethnicity, sex, and language on delay to hospital arrival for acute ischemic stroke. Stroke. 2010;41:905–9.PubMedCentralCrossRefPubMed Smith MA, Lisabeth LD, Bonikowski F, Morgenstern LB. The role of ethnicity, sex, and language on delay to hospital arrival for acute ischemic stroke. Stroke. 2010;41:905–9.PubMedCentralCrossRefPubMed
14.
go back to reference Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, et al. Time to treatment with intravenous tissue Plasminogen Activator and outcome from acute ischemic stroke. JAMA. 2013;309:2480–8.CrossRefPubMed Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, et al. Time to treatment with intravenous tissue Plasminogen Activator and outcome from acute ischemic stroke. JAMA. 2013;309:2480–8.CrossRefPubMed
15.
go back to reference Madsen TE, Khoury JC, Alwell KA, Moomaw CJ, Kissela BM, et al. Analysis of tissue plasminogen activator eligibility by sex in the greater Cincinnati/Northern Kentucky stroke study. Stroke. 2015;46:717–21.CrossRefPubMed Madsen TE, Khoury JC, Alwell KA, Moomaw CJ, Kissela BM, et al. Analysis of tissue plasminogen activator eligibility by sex in the greater Cincinnati/Northern Kentucky stroke study. Stroke. 2015;46:717–21.CrossRefPubMed
Metadata
Title
The Women Independently Living Alone with a Medical Alert Device (WILMA) trial
Authors
Lewis B. Morgenstern
Eric E. Adelman
Rebecca Hughes
Jeffrey J. Wing
Lynda D. Lisabeth
Publication date
01-10-2015
Publisher
Springer US
Published in
Translational Stroke Research / Issue 5/2015
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-015-0411-0

Other articles of this Issue 5/2015

Translational Stroke Research 5/2015 Go to the issue